DE68905886D1 - Calcitoninzusammensetzung zur intranasalen verabreichung. - Google Patents

Calcitoninzusammensetzung zur intranasalen verabreichung.

Info

Publication number: DE68905886D1
Authority: DE; Germany
Prior art keywords: calciton; composition; intranasal administration; intranasal; administration
Prior art date: 1988-09-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE8989116685T

Other languages

English (en)

Other versions

DE68905886T2 (de

Inventor

Klunk, Jr

Peter E Grebow

Herschel H Li

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Rhone Poulenc Rorer International Holdings Inc

Original Assignee

Rhone Poulenc Rorer International Holdings Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-09-08

Filing date

1989-09-08

Publication date

1993-05-13

1989-09-08 Application filed by Rhone Poulenc Rorer International Holdings Inc filed Critical Rhone Poulenc Rorer International Holdings Inc

1993-05-13 Application granted granted Critical

1993-05-13 Publication of DE68905886D1 publication Critical patent/DE68905886D1/de

1993-07-15 Publication of DE68905886T2 publication Critical patent/DE68905886T2/de

2009-09-09 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oil, Petroleum & Natural Gas (AREA)
Otolaryngology (AREA)
Hematology (AREA)
Obesity (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

DE8989116685T 1988-09-08 1989-09-08 Calcitoninzusammensetzung zur intranasalen verabreichung. Expired - Fee Related DE68905886T2 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/242,000 US5026825A (en)	1988-09-08	1988-09-08	Intranasal calcitonin formulations

Publications (2)

Publication Number	Publication Date
DE68905886D1 true DE68905886D1 (de)	1993-05-13
DE68905886T2 DE68905886T2 (de)	1993-07-15

Family

ID=22913078

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE8989116685T Expired - Fee Related DE68905886T2 (de)	1988-09-08	1989-09-08	Calcitoninzusammensetzung zur intranasalen verabreichung.

Country Status (5)

Country	Link
US (1)	US5026825A (de)
EP (1)	EP0358234B1 (de)
JP (1)	JPH02115130A (de)
DE (1)	DE68905886T2 (de)
ES (1)	ES2061851T3 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5446070A (en) *	1991-02-27	1995-08-29	Nover Pharmaceuticals, Inc.	Compositions and methods for topical administration of pharmaceutically active agents
WO1991013601A1 (en) *	1990-03-15	1991-09-19	Rhône-Poulenc Rorer International (Holdings) Inc.	Calcitonin suppository formulations
JPH078806B2 (ja) *	1990-08-16	1995-02-01	旭化成工業株式会社	カルシトニン類含有経鼻投与用乳剤
EP0489217A1 (de) *	1990-12-05	1992-06-10	Dr. A. Tosi Farmaceutici S.R.L.	Calcitoninzusammensetzungen zur intranasalen Verabreichung
JP3179538B2 (ja) *	1990-12-11	2001-06-25	ノバルティスアクチエンゲゼルシャフト	安定なヒトカルシトニンの水性溶液
GB9102579D0 (en) *	1991-01-24	1991-03-27	Glaxo Group Ltd	Compositions
US5688761A (en) *	1991-04-19	1997-11-18	Lds Technologies, Inc.	Convertible microemulsion formulations
CA2108266C (en) *	1991-04-19	2003-06-03	Albert J. Owen	Convertible microemulsion formulations
US5571788A (en) *	1991-12-09	1996-11-05	Ciba-Geigy Corporation	Stable calcitonin pharmaceutical compositions
EP0736041B1 (de) *	1993-11-17	2006-02-08	Athena Neurosciences, Inc.	Transparente flüssigkeit zur verabreichung von verkapselten medikamenten
EP0726075A1 (de) *	1995-02-08	1996-08-14	Therapicon Srl	Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
US5698672A (en) *	1995-04-04	1997-12-16	Zymogenetics, Inc.	Synthetic calcitonin mimetics
DE19744811C2 (de) *	1997-10-02	1999-11-18	Medac Klinische Spezialpraep	Verwendung von delta-Aminolävulinsäure zur Herstellung eines topischen Arzneimittels zur integralen Diagnose und/oder Therapie von Tumoren in Hohlorganen
US6187332B1 (en) *	1999-06-14	2001-02-13	Wisconsin Alumni Research Foundation	Acidic buffered nasal spray
US6398774B1 (en) *	1999-09-29	2002-06-04	Heska Corporation	Intranasal delivery system
DE10003620A1 (de) *	2000-01-28	2001-08-02	Asat Ag Applied Science & Tech	5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
AU783952B2 (en)	2000-02-04	2006-01-05	Unigene Laboratories, Inc.	Nasal calcitonin formulations
US7812120B2 (en)	2003-03-21	2010-10-12	Par Pharmaceutical, Inc.	Nasal calcitonin formulations containing chlorobutanol
US20050175679A1 (en) *	2004-02-10	2005-08-11	Michael Moshman	Controlled release formulations
US7989420B2 (en)	2006-03-28	2011-08-02	New York Medical College	Smooth muscle relaxation
MX338110B (es) *	2009-09-25	2016-04-01	Reddys Lab Ltd Dr	Formulaciones que comprenden compuestos de triptano.
US11337962B2 (en)	2009-09-25	2022-05-24	Upsher-Smith Laboratories, Llc	Formulations comprising triptan compounds
GB202201708D0 (en) *	2022-02-10	2022-03-30	Intract Pharma Ltd	Compositions for oral delivery of biotherapeutics

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
LU65921A1 (de) *	1972-08-18	1974-02-21
US4568665A (en) *	1982-06-25	1986-02-04	Mitchell David C	Protein compounds
GB8514090D0 (en) *	1985-06-04	1985-07-10	Sandoz Ltd	Organic compounds
US4692433A (en) *	1983-10-12	1987-09-08	The Regents Of The University Of California	Method and composition for regulating serum calcium levels of mammals
JPS6160620A (ja) *	1984-09-03	1986-03-28	Teijin Ltd	ピログルタミン酸エステル類を含有する医薬品組成物
JPS61267528A (ja) *	1984-11-26	1986-11-27	Yamanouchi Pharmaceut Co Ltd	吸収促進剤を含有するカルシトニン経鼻剤
HUT44794A (en) *	1985-12-04	1988-04-28	Sandoz Ag	Process for production of calcitonine-derivatives and medical preparatives containing such compounds
US4746728A (en) *	1986-05-05	1988-05-24	Armour Pharmaceutical Company	8-glycine, des-19-leucine-calcitonin
MY102411A (en) *	1986-12-23	1992-06-17	Ciba Geigy Ag	Nasal solutions
IL91856A0 (en) *	1988-10-11	1990-06-10	Schiapparelli Salute Spa	Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same

1988
- 1988-09-08 US US07/242,000 patent/US5026825A/en not_active Expired - Lifetime
1989
- 1989-09-08 EP EP89116685A patent/EP0358234B1/de not_active Expired - Lifetime
- 1989-09-08 JP JP1231803A patent/JPH02115130A/ja active Pending
- 1989-09-08 ES ES89116685T patent/ES2061851T3/es not_active Expired - Lifetime
- 1989-09-08 DE DE8989116685T patent/DE68905886T2/de not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JPH02115130A (ja)	1990-04-27
US5026825A (en)	1991-06-25
DE68905886T2 (de)	1993-07-15
EP0358234A3 (en)	1990-10-31
EP0358234B1 (de)	1993-04-07
ES2061851T3 (es)	1994-12-16
EP0358234A2 (de)	1990-03-14

Publication	Publication Date	Title
DE3884461D1 (de)	1993-11-04	Antibiotikum-polymer zusammensetzung.
DE3864883D1 (de)	1991-10-24	Suessungsmittel-zusammensetzung.
DE68907659D1 (de)	1993-08-26	Warmhaertende organosiloxanzusammensetzung.
DE68905886D1 (de)	1993-05-13	Calcitoninzusammensetzung zur intranasalen verabreichung.
FI891395L (fi)	1989-09-25	Eldbestaendig olefinhartskomposition.
FI910976A0 (fi)	1991-02-27	Komposition foer behandling av erektil dysfunktion.
FI883238A0 (fi)	1988-07-06	Mikrobicid komposition.
DE3870011D1 (de)	1992-05-21	Hartbutter-zusammensetzung.
DE68913693D1 (de)	1994-04-14	Aerosol-Zusammensetzung.
DE3867594D1 (de)	1992-02-20	Zementzusammensetzung.
DE3786252D1 (de)	1993-07-22	Gummi-zusammensetzung.
DE3874313D1 (de)	1992-10-08	Kautschukzusammensetzung.
FI883517L (fi)	1990-01-27	Traekonstruktion.
AR244544A1 (es)	1993-11-30	Composicion desodorante.
DE68916395D1 (de)	1994-07-28	Zusammensetzung.
FI893643A0 (fi)	1989-08-01	Farmaceutiska kompositioner.
DE3863957D1 (de)	1991-09-05	Zementzusammensetzungen.
DE3883952D1 (de)	1993-10-14	Gummi-Zusammensetzung.
FI893740L (fi)	1990-02-11	Orala aemneskompositioner.
FI880158A0 (fi)	1988-01-14	Diuretisk komposition.
FI883673A0 (fi)	1988-08-05	Farmaceutiska kompositioner.
DE3869471D1 (de)	1992-04-30	Fiebersteigende zusammensetzung.
DE3874071D1 (de)	1992-10-01	Zahnsteinverhindernde zusammensetzung.
FI892744L (fi)	1989-12-07	Flocklimkomposition.
DE3887827D1 (de)	1994-03-24	Kautschuk-Zusammensetzung.

Legal Events

Date	Code	Title	Description
1994-05-05	8364	No opposition during term of opposition
1994-09-08	8339	Ceased/non-payment of the annual fee